Creating and leading a high‑performing cross‑functional team of global functional senior leaders responsible for the delivery of the product portfolio
Creating ambitious development plans and options for each of their assets, with the goal of managing the tradeoff between time, risk, cost and value
Accountable for the development and commercialization of development product(s) from 6‑12 months prior to SG2
Drive maximum patient value for growth brands contributing to R&D value targets through life cycle management including, label expansions, novel technologies and development of combination products, and new indications
Asset Manager (or Member of Asset Management Forum - if relevant); responsible for global cross‑TA strategy, oversight and management of product label, identification of resource synergies and allocation of license maintenance support in support of continued and maximized value generation